174 related articles for article (PubMed ID: 32494162)
41. Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells.
Wang W; Liu B; Sun S; Lan L; Chen Y; Han S; Li X; Li Z
Onco Targets Ther; 2020; 13():1649-1659. PubMed ID: 32158231
[TBL] [Abstract][Full Text] [Related]
42. circPDK1 competitively binds miR-4731-5p to mediate GIGYF1 expression and increase paclitaxel sensitivity in non-small cell lung cancer.
Feng Y; Zhang T; Liu H
Discov Oncol; 2024 May; 15(1):157. PubMed ID: 38733530
[TBL] [Abstract][Full Text] [Related]
43. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
44. Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway.
Jiang L; Hou R
Onco Targets Ther; 2020; 13():3631-3639. PubMed ID: 32431514
[TBL] [Abstract][Full Text] [Related]
45. Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets.
Kaya M; Abuaisha A; Suer I; Emiroglu S; Abanoz F; Palanduz S; Cefle K; Ozturk S
Eur J Breast Health; 2024 Apr; 20(2):102-109. PubMed ID: 38571691
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7.
Wu X; Chen H; Wu M; Peng S; Zhang L
Ann Transl Med; 2020 Aug; 8(16):995. PubMed ID: 32953795
[TBL] [Abstract][Full Text] [Related]
47. Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.
Chimplee S; Roytrakul S; Sukrong S; Srisawat T; Graidist P; Kanokwiroon K
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056723
[TBL] [Abstract][Full Text] [Related]
48. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.
Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
50. [miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5].
Zhou D; Bai J; Hu Y; Zhang L; Zheng Q; Zhong W; Mu Q; Li H; Lyu S; Yin C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):794-801. PubMed ID: 32967763
[TBL] [Abstract][Full Text] [Related]
51. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of lncRNA
Shi R; Wu P; Liu M; Chen B; Cong L
Onco Targets Ther; 2020; 13():3025-3037. PubMed ID: 32308433
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of miR-483-5p improves the proliferation, invasion and inflammatory response of triple-negative breast cancer cells by targeting SOCS3.
Ren J; Xu G; Sun H; Lin T; Xu S; Zhao Y
Exp Ther Med; 2021 Oct; 22(4):1047. PubMed ID: 34434261
[TBL] [Abstract][Full Text] [Related]
55. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
56. miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.
Ma C; Shi X; Guo W; Feng F; Wang G
Exp Ther Med; 2019 Nov; 18(5):3525-3533. PubMed ID: 31602229
[TBL] [Abstract][Full Text] [Related]
57. Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
Astarita EM; Maloney SM; Hoover CA; Berkeley BJ; VanKlompenberg MK; Nair TM; Prosperi JR
PLoS One; 2021; 16(8):e0255738. PubMed ID: 34370741
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
59. Long Noncoding RNA
Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
[No Abstract] [Full Text] [Related]
60. Long Noncoding-RNA Component of Mitochondrial RNA Processing Endoribonuclease Promotes Carcinogenesis in Triple-Negative Breast Cancer Cells via the Competing Endogenous RNA Mechanism.
Qi L; Sun B; Yang B; Lu S
J Breast Cancer; 2021 Oct; 24(5):428-442. PubMed ID: 34652079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
